According to Verona Pharma's latest financial reports the company has $0.24 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.24 B | 8.16% |
2022-12-31 | $0.23 B | 55.72% |
2021-12-31 | $0.14 B | -19.93% |
2020-12-31 | $0.18 B | 229.82% |
2019-12-31 | $56.04 M | -45.13% |
2018-12-31 | $0.10 B | -29.99% |
2017-12-31 | $0.14 B | 177.82% |
2016-12-31 | $52.51 M | 340.23% |
2015-12-31 | $11.92 M | -60.94% |
2014-12-31 | $30.54 M | 443% |
2013-12-31 | $5.62 M | -17.28% |
2012-12-31 | $6.8 M | -30.3% |
2011-12-31 | $9.75 M | 18.65% |
2010-12-31 | $8.22 M | -29.89% |
2009-12-31 | $11.72 M | 36.81% |
2008-12-31 | $8.57 M | -24.66% |
2007-12-31 | $11.37 M | -24.15% |
2006-12-31 | $15 M | 417.97% |
2005-12-31 | $2.89 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$2.88 M | -101.15% | Bahamas |
NRC Health
NRC | $48.95 M | -80.36% | ๐บ๐ธ USA |